PWR
63
3
MA
60
5
WBA
41
3
CNX
67
4
JCI
44
7
EMC
30
-26
BDX
59
3
RL
73
5
FTI
61
5
MET
58
2
GOOGL
62
6
GE
60
5
EBAY
42
2
EMR
57
7
SWK
53
4
CAH
44
7
IVZ
42
13
F
38
4
KSS
36
2
WM
53
2
PWR
63
3
MA
60
5
WBA
41
3
CNX
67
4
JCI
44
7
EMC
30
-26
BDX
59
3
RL
73
5
FTI
61
5
MET
58
2
GOOGL
62
6
GE
60
5
EBAY
42
2
EMR
57
7
SWK
53
4
CAH
44
7
IVZ
42
13
F
38
4
KSS
36
2
WM
53
2
Financhill
Back

West Pharmaceutical Services 10K Form

Sell
45

WST
West Pharmaceutical Services

Last Price:
$331.54
Seasonality Move:
6.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-25 10Q WST/West Pharmaceutical Services Quarterly
2023-10-26 10Q WST/West Pharmaceutical Services Quarterly
2023-07-27 10Q WST/West Pharmaceutical Services Quarterly
2023-04-27 10Q WST/West Pharmaceutical Services Quarterly
2022-10-27 10Q WST/West Pharmaceutical Services Quarterly
2022-07-28 10Q WST/West Pharmaceutical Services Quarterly

Receive WST News And Ratings

See the #1 stock for the next 7 days that we like better than WST

WST Financial Statistics

Sales & Book Value

Annual Sales: $2.9B
Cash Flow: $98.8M
Price / Cash Flow: 76.28
Annual Sales: $37.96
Price / Book: 8.72

Profitability

EPS (TTM): 6.74000
Net Income (TTM): $499.6M
Gross Margin: $1.1B
Return on Equity: 18.16%
Return on Assets: 13.61%

West Pharmaceutical Services Earnings Forecast

Key West Pharmaceutical Services Financial Ratios

  • The Gross Profit Margin over the past 40 years for WST is 38.28%.
  • The Selling, General & Administrative Expenses for WST have been equal to 11.98% of Gross Profit Margin.
  • The Research & Development expenses have been 2.32% of Revenue.
  • The Interest Expense is 1.52% of Operating Income.
  • The Net Earning history of WST is 20.12% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

West Pharmaceutical Services Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: WST
CUSIP: 955306
Website: westpharma.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 3
Quick Ratio: 1.97

Price-to-Earnings

Trailing P/E Ratio: 42.06
Forward P/E Ratio: 44.2

WST Technical Analysis vs Fundamental Analysis

Sell
45
West Pharmaceutical Services (WST) is a Sell

Is West Pharmaceutical Services a Buy or a Sell?